These are this Tuesday’s top analyst upgrades and downgrades from 24/7 Wall St.
Abengoa S.A. (NASDAQ: ABGB) was maintained as Buy and listed as a Best Idea with a $44 price target at Canaccord Genuity.
Avago Technologies Ltd. (NASDAQ: AVGO) was reiterated as Outperform by Pacific Crest, but the price target was raised to $90 from $85.
American Water Works Inc. (NYSE: AWK) was downgraded to Market Perform from Outperform at Wells Fargo.
Cabot Oil & Gas Corp. (NYSE: COG) was raised to Buy from Hold at Stifel
Exelixis Inc. (NASDAQ: EXEL) has halted its prostate cancer drug development after not meeting its endpoint, seeing its shares more than halved. The biotech was downgraded to Market Perform from Outperform at Cowen & Co.
Endo International PLC (NASDAQ: ENDP) was started with an Outperform rating at RBC Capital Markets.
Energy Transfer Partners L.P. (NYSE: ETP) was reinstated as Neutral at Credit Suisse, but the upside price target of $64 (versus a $57.45 close) hardly sounds like a Neutral rating when you consider there is also a distribution rate above 6%.
Gap Inc. (NYSE: GPS) was reiterated as Buy with a $52 price target (versus a $46.15 close) at Sterne Agee, but the firm also said Gap is its top retail pick for the second half of 2014.
Groupon Inc. (NASDAQ: GRPN) was raised to Sector Perform from Sector Underperform at RBC Capital Markets, and the price target was raised to $6 from $5 (versus a $7 close) in the call.
iDreamSky Technology Ltd. (NASDAQ: DSKY) was started with an Overweight rating and $30 price target (versus a $20.59 close) at Piper Jaffray.
READ ALSO: Just 15 Companies Have $1.2 Trillion in Combined Backlog
Life Time Fitness Inc. (NYSE: LTM) was raised to Overweight from Neutral at Piper Jaffray.
Northrop Grumman Corp. (NYSE: NOC) was raised to Outperform from Sector Perform at RBC Capital Markets, and the price target was raised to $148 from $143 (versus a $127.22 close).
Progressive Corp. (NYSE: PGR) was raised to Buy from Neutral and was given a $28 price target (versus a $25.02 close) by Goldman Sachs.
PulteGroup Inc. (NYSE: PHM) was downgraded to Market Perform from Outperform at FBR Capital Markets.
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was reiterated as Outperform at Credit Suisse and the price target was raised to $400 from $340 (versus a $350.52 close).
SandRidge Energy Inc. (NYSE: SD) was raised to Buy from Hold with a $6.75 price target (versus a $5.24 close) at Stifel.
Staples Inc. (NASDAQ: SPLS) was raised to Outperform from Neutral and given a $15 price target (versus a $11.68 close) at Credit Suisse.
Tesla Motors Inc. (NASDAQ: TSLA) was raised to Buy from Hold with a $400 price target (versus a $269.70 close) at Stifel. We also asked on Monday, can Tesla become more valuable than General Motors?
READ ALSO: The Alibaba IPO Will Dominate Syndicate Market News
Top Gaining Stocks
Top Losing Stocks